Omega Fund V GP Manager, Ltd.

CIK 1641348 · last filed 2021-12-17

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Disclosed Exposure

$15.36M

Companies

Total Filings

Lifetime Open-Market Net

-$114.19M

Charts

Trading activity, where the exposure sits, and each trade against the stock price.

NUVB.WS price and trades

Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.

Shares held

Shares owned after each reported transaction on this company (direct holdings as reported).

Open-market buying and selling

by month

Dollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.

Exposure by company

latest

OfficerDirector10% owner* stale (no filing in 3 yrs)

Most recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.

Filer Profile

Reported Address

888 BOYLSTON ST., SUITE 1111
BOSTON, MA 02199

Phone

(617) 502-6538

State of Incorporation

Cayman Islands

Related Filers

Omega Fund V, L.P. — 62 joint filings, latest 2022-04-07

Omega Fund V GP, L.P. — 61 joint filings, latest 2022-04-07

Otello Stampacchia — 53 joint filings, latest 2021-05-03

Claudio Nessi — 9 joint filings, latest 2021-02-12

Anne-Mari Paster — 9 joint filings, latest 2021-02-12

Richard J. Lim — 5 joint filings, latest 2019-07-01

Omega Fund IV GP, L.P. — 3 joint filings, latest 2021-12-17

Anna Guyer Mitsak — 2 joint filings, latest 2019-05-13

Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.

Symbol	Role	Shares	Price	Disclosed Exposure	Lifetime OM Net	Filings	Latest Filed
Nuvation Bio Inc. (NUVB.WS) Delisted	10%+ Owner	22,957,340	$0.01	$117.1K	-$70.61M	2	2021-12-17
Morphic Holding, Inc. (MORF) Delisted	Director	2,094,186	$56.99	$119.35M	-$43.57M	12	2021-04-29
GOSS	10%+ Owner	168,836	$9.46	$1.60M	-$19.25M	3	2019-09-23
TRVI	10%+ Owner	1,063,408	$12.94	$13.76M	$19.24M	1	2019-05-13

Recent Filings · Page 2 of 2

18 filings

Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.

Filed	Symbol	Action	Net Shares	Net $	Link
2021-01-19	Morphic Holding, Inc. (MORF) Delisted	Sell (S)	−94,120	-$2.87M	EDGAR
2021-01-12	Morphic Holding, Inc. (MORF) Delisted	Sell (S)	−49,636	-$1.50M	EDGAR
2021-01-08	Morphic Holding, Inc. (MORF) Delisted	Sell (S)	−112,660	-$3.38M	EDGAR
2021-01-04	Morphic Holding, Inc. (MORF) Delisted	Sell (S)	−63,568	-$2.10M	EDGAR
2019-09-23	GOSS	Sell (S)	−550,821	-$12.10M	EDGAR
2019-09-18	GOSS	Sell (S)	−328,852	-$7.15M	EDGAR
2019-05-13	TRVI	Mixed	+4,253,632	$19.24M	EDGAR
2019-02-12	GOSS	Conv (C)	+27,813,664	$0	EDGAR

Showing 11–18 of 18

Prev Page 2 of 2

Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.